Breaking News
April 19, 2019 - New insights into how vitamin D affects immune system
April 19, 2019 - Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
April 19, 2019 - Exercise can improve non-motor symptoms of Parkinson’s disease
April 19, 2019 - KZFPs play a key role in the regulation of human genome
April 19, 2019 - Extracts of ginkgo seeds show antibacterial activity on pathogens that cause skin infections
April 19, 2019 - Exercises and swimming goggles may reduce adverse effects on eye during long spaceflights
April 19, 2019 - Review suggests a reciprocal relationship between obesity and self-control
April 19, 2019 - Study identifies how enterococci bacteria cause antibiotic-resistant bloodstream infections
April 19, 2019 - Triple negative breast cancer develop resistance to chemotherapy by turning on molecular pathway
April 19, 2019 - Researchers identify key clues to brain and pancreas development
April 19, 2019 - Metformin May Cut Risk for Prematurity, Miscarriage in PCOS
April 19, 2019 - Obese mouse mothers trigger heart problems in offspring
April 19, 2019 - Research sheds light on how leukemia cells become resistant to drugs
April 19, 2019 - Health Tip: Stopping Nosebleeds – Drugs.com MedNews
April 19, 2019 - Pediatric endocrinologist gives iconic ‘Mona Lisa’ a second medical opinion
April 19, 2019 - Tapping patients’ wisdom for C-section pain management
April 18, 2019 - Why have autism rates ‘exploded’ in New Jersey?
April 18, 2019 - Microbiome science may help doctors to improve treatment for children with IBS
April 18, 2019 - New gene therapy cures babies with fatal ‘Bubble Boy’ disease
April 18, 2019 - No female mice? Scientists may still approve NIH grant
April 18, 2019 - What needs to be said about mental health in medicine
April 18, 2019 - Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
April 18, 2019 - Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
April 18, 2019 - Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
April 18, 2019 - Adhesive gel bonds to eye surface, could repair injuries without surgery
April 18, 2019 - The future of genomics: A podcast featuring Stanford geneticists
April 18, 2019 - As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
April 18, 2019 - APOE gene impacts sleep depending on gender and severity of Alzheimer’s
April 18, 2019 - PCORI’s newly approved awards focus on cancer pain and opioid use disorders
April 18, 2019 - New tool provides a standard way to measure effects of caring for survivors of TBI
April 18, 2019 - Smartphone use risks eye examination misdiagnosis
April 18, 2019 - How drug-resistant bugs grow in CF patients’ lungs
April 18, 2019 - Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
April 18, 2019 - Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
April 18, 2019 - Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
April 18, 2019 - New estimation method assesses natural variations in sex ratio at birth
April 18, 2019 - UTA scientist receives $1.17 million grant for cancer research
April 18, 2019 - Coagulation factor VIIa prevents bleeds in hemophilia animal models
April 18, 2019 - Researchers identify risk factors for severe infection after knee replacement
April 18, 2019 - Mass drug administration can offer community-level protection against malaria
April 18, 2019 - FDA’s added sugar label could have substantial health and cost-saving benefits
April 18, 2019 - Researchers identify cause of inherited metabolic disorder
April 18, 2019 - Single strip of white paint not sufficient to protect people who ride bikes
April 18, 2019 - Partner status influences link between sexual problems and self-efficacy in breast cancer survivors
April 18, 2019 - Colorectal Neoplasia Risk Up for Hodgkin Lymphoma Survivors
April 18, 2019 - Rigid spine muscular dystrophy – Genetics Home Reference
April 18, 2019 - Simple bile acid blood test could tell risk of stillbirth
April 18, 2019 - Center for Experimental Therapeutics aims to enable all steps of drug development | News Center
April 18, 2019 - Falling for telephone scams could be an early sign of dementia
April 18, 2019 - Researchers annotate key neuronal proteins in lamprey genome
April 18, 2019 - Study uncovers new biomarker for personalized cancer treatments
April 18, 2019 - Scientists enter research collaboration to find a cure for cancer
April 18, 2019 - Study to compare benefits of tai chi and mindfulness meditation on MS symptoms
April 18, 2019 - Gestational diabetes during pregnancy may increase risk of type 1 diabetes in children
April 18, 2019 - Maternal age has no effect on IVF success, conclude researchers
April 18, 2019 - Is a New Remedy for Body Odor on the Horizon?
April 18, 2019 - Orthostatic hypotension – Genetics Home Reference
April 18, 2019 - Healing the heartbreak of stillbirth and newborn death
April 18, 2019 - New study calls healthiness of eggs into question
April 18, 2019 - Conference to highlight advances in human immune monitoring, bioinformatics | News Center
April 18, 2019 - Bacteria use viruses for self-recognition, study reveals
April 18, 2019 - New adhesive patch could help reduce post-heart attack muscle damage
April 18, 2019 - Researchers analyze the effects of dark play in a serious video game
April 18, 2019 - Scientists revive pig brain cells four hours after death
April 18, 2019 - Filial cannibalism and offspring abandonment may be forms of parental care
April 18, 2019 - Two proteins act in concert to maintain a healthy heart in mice, shows study
April 18, 2019 - Scientists create a functioning 3D printed heart
April 18, 2019 - Non-invasive vagus nerve stimulation improves disease symptoms in patients with rheumatoid arthritis
April 18, 2019 - Majority of men struggle to understand diagnosis and treatment of prostate cancer
April 18, 2019 - Researchers create new small molecules that may combat equine encephalitis viruses
April 18, 2019 - Animal-assisted therapy improves social behavior in patients with brain injuries
April 18, 2019 - Some viruses help protect harmful bacteria in CF patients | News Center
April 18, 2019 - Outpatient healthcare providers inappropriately prescribe antibiotics to 40% of patients
April 18, 2019 - Men who have a resting heart rate of 75 bpm are twice as likely to die early
April 18, 2019 - Novel serum biomarkers to detect NAFLD-related fibrosis
April 18, 2019 - New study delves deeper into individual genomic differences than ever before
April 18, 2019 - Gilead and Galapagos Announce Filgotinib Meets Primary Endpoint in the Phase 3 FINCH 3 Study in Methotrexate-Naïve Rheumatoid Arthritis Patients
April 18, 2019 - Emotional mirror neurons found in rats
April 18, 2019 - Sylvia Plevritis appointed chair of biomedical data science | News Center
April 18, 2019 - Cervical cancer subtype increasing in several subpopulations of women
Scientists identify how viral protein promotes fatal disease caused by Nipah and Hendra viruses

Scientists identify how viral protein promotes fatal disease caused by Nipah and Hendra viruses

image_pdfDownload PDFimage_print

Researchers have identified how a viral protein, which plays a major role in causing deadly Nipah and Hendra virus infections, targets a critical function in human cells to suppress immune responses and promote fatal disease.

The research team found the viral protein, called W protein, binds to two specific proteins in the host cell, importin α3 and importin α4, allowing it to move into the nucleus of cells. This allows the protein to disable defenses that protect cells from infection and promote growth of Nipah and Hendra viruses. The findings are published in the journal Nature Communications.

Nipah and Hendra viruses, closely related zoonotic pathogens that come from animal sources, are highly lethal in humans. Old World fruit bats are the source of both viruses in nature.

Hendra virus infections have been identified in Australia, mostly in veterinarians who were caring for horses. Scientists believe the virus passed from bats to horses, and then veterinarians came in contact with the sick horses.

Nipah virus was originally discovered in Malaysia in 1998. There was an outbreak of encephalitis, one of the symptoms of Nipah virus, in people working on pig farms. Scientists believe bats transmitted the virus to these pigs, and then people who came in contact with the infected pigs became sick. Forty percent of the people who became ill died. More recently, Nipah virus infections have been recognized in Bangladesh and India, with 70 to 75 percent fatality rates. This time, there seems to be a more direct transmission of the virus from bats to people.

“Right now, for humans, we lack any licensed vaccines or approved drugs to treat the infections,” said Dr. Christopher Basler, senior author of the study, professor in the Institute for Biomedical Sciences and director of the Center for Microbial Pathogenesis at Georgia State University and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis. “We need vaccines, we need treatments, and we also need to better understand what makes the viruses so deadly.

“The protein we’re studying is called the W protein. We’ve been studying this protein for several years because it suppresses innate immune responses. This means that it blocks the very early defenses that should protect us from virus infection.”

In previous work, Basler and his colleagues at the University of Texas Medical Branch at Galveston have studied the behavior of Nipah virus in animals. They wanted to understand how important W protein is for the ability of the virus to cause disease. Using facilities at University of Texas Medical Branch at Galveston, they engineered a Nipah virus that couldn’t produce the W protein and then put this modified virus into animals. This changed the course of disease and demonstrated that the function of the W protein is important for Nipah virus to cause disease.

In this study, a research team led by Dr. Jade K. Forwood of Charles Sturt University in Australia used structural biology approaches to investigate how the W protein travels from the cytoplasm to the nucleus of the cell through the interaction of W protein with importin α proteins, which allow the W protein to get into the nucleus. The Basler laboratory at Georgia State performed studies in living cells to investigate the W protein interaction with importin α proteins and define why this interaction is important for W protein function. In prior work, Basler has found the ability of the W protein to enter into the nucleus is important for its ability to block innate immune responses.

“One of the things that’s interesting about the W protein being in the nucleus of the cell is that most of the other components of the virus remain in the cytoplasm of the cell throughout the replication cycle,” Basler said. “We think that the W protein goes to the nucleus to do something, to somehow specifically target innate immune responses.”

Human cells have seven different kinds of importin α proteins. In this study, the researchers found W protein is using two of them, importin α3 and importin α4, to get into the nucleus. They identified specific features on the W protein that allow it to recognize those two members of the importin α protein family and distinguish them from others.

“We’re trying to understand how it selectively uses two of the seven family members for this,” Basler said. “There’s a broader biological question there. We don’t really understand how this selectivity works or even really why it’s important. We’re trying to better understand the basis of that selectivity.

“I think you can argue that by understanding this, it may suggest strategies by which we can try to block the interaction between the viral protein (W) and the host protein (importin) that might be useful in terms of developing therapies that are designed to block this virus. If you had a drug that somehow prevented that interaction, W would no longer carry on its normal function and that would attenuate the virus and make it less able to cause disease.”

Tagged with:

About author

Related Articles